Role of eicosanoids in prostate cancer progression

Cancer and Metastasis Reviews

Volumn 20, Issue 3-4, 2001, Pages 195-206

  Nie, Daotai ^a   Che, Mingxin ^a   Grignon, David ^a   Tang, Keqin ^a   Honn, Kenneth V ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Cyclooxygenase; Eicosanoid; Lipoxygenase; Tumor metastasis

Indexed keywords

CYTOCHROME P450; ICOSANOID; LIPOXYGENASE; PROSTAGLANDIN SYNTHASE;

APOPTOSIS; ARACHIDONIC ACID METABOLISM; CANCER GROWTH; CANCER INVASION; CELL PROLIFERATION; ENZYME ACTIVITY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; RECEPTOR UPREGULATION; REVIEW;

EID: 0035740016     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015579209850     Document Type: Review

References (53)

1. Prostate cancer risk and consumption of fish oils: A dietary biomarker-based case-control study
2. Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma
3. Expression of cyclooxygenase-2 in prostate adenocarcinoma and benign prostatic hyperplasia
4. Expression of cyclooxygenase-2 in prostate carcinoma
5. Expression of cyclooxygenase-1 and cyclooxygenase-2 in the human prostate
6. Increased expression of cyclooxygenase-2 and nitric oxide synthase-2 in human prostate cancer
7. Differential expression of cyclooxygenase-2 and its regulation by tumor necrosis factor-alpha in normal and malignant prostate cells
8. Induction of cyclooxygenase-2 mRNA by prostaglandin E2 in human prostatic carcinoma cells
9. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells
10. The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2
11. Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines
12. Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line
13. Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo
14. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential
15. Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases
16. Lipoxygenase-5 is overexpressed in prostate adenocarcinoma
17. 15-Lipoxygenase-2 (15-LOX-2) is expressed in benign prostatic epithelium and reduced in prostate adenocarcinoma
18. 5-Lipoxygenase inhibitors reduce PC-3 cell proliferation and initiate nonnecrotic cell death
19. Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells
20. Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis
21. 5-Lipoxygenase-activating protein (FLAP)
22. A relationship between 5-lipoxygenase-activating protein and bcl-xL expression in murine pro-B lymphocytic FL5.12 cells
23. The 5-lipoxygenase-activating protein (FLAP) inhibitor, MK886, induces apoptosis independently of FLAP
24. Inhibition of peroxisome-proliferator-activated receptor (PPAR)alpha by MK886
25. 12-Lipoxygenases and 12(S)-HETE: Role in cancer metastasis
26. 12-Lipoxygenase in Lewis lung carcinoma cells: Molecular identity, intracellular distribution of activity and protein, and Ca(2+)-dependent translocation from cytosol to membranes
27. Endogenous 12(S)-HETE production by tumor cells and its role in metastasis
28. Biosynthesis of 12(S)-hydroxyeicosatetraenoic acid by B16 amelanotic melanoma cells is a determinant of their metastatic potential
29. Autocrine motility factor induces differential 12-lipoxygenase expression and activity in high- and low-metastatic K1735 melanoma cell variants
30. Elevated 12-lipoxygenase mRNA expression correlates with advanced stage and poor differentiation of human prostate cancer
31. Platelet-type 12-lipoxygenase in a human prostate carcinoma stimulates angiogenesis and tumor growth
32. Enhanced angiogenesis and growth of 12-lipoxygenase gene-transfected MCF-7 human breast cancer cells in athymic nude mice
33. PKC mediates 12(S)-HETE-induced cytoskeletal rearrangement in B16a melanoma cells
34. Differential secretion of cathepsins B and L from normal and tumor human lung cells stimulated by 12(S)-hydroxyeicosatetraenoic acid
35. Immunomorphological characterization and effects of 12-(S)-HETE on a dynamic intracellular pool of the alpha IIb beta 3-integrin in melanoma cells
36. Enhanced tumor cell adhesion to the subendothelial matrix resulting from 12(S)-HETE-induced endothelial cell retraction
37. 12(S)-hydroxyeicosatetraenoic acid and 13(S)-hydroxyoctadecadienoic acid regulation of protein kinase C-alpha in melanoma cells: Role of receptor-mediated hydrolysis of inositol phospholipids
38. Eicosanoid activation of extracellular signal-regulated kinase1/2 in human epidermoid carcinoma cells
39. Eicosanoid 12(S)-HETE activates phosphatidylinositol 3-kinase
40. 12(S)-HETE enhancement of prostate tumor cell invasion: Selective role of PKC alpha
41. Arachidonate lipoxygenases as essential regulators of cell survival and apoptosis
42. Eicosanoid regulation of angiogenesis: Role of endothelial arachidonate 12-lipoxygenase
43. Discovery of a second 15S-lipoxygenase in humans
44. Production of 13-hydroxyoctadecadienoic acid (13-HODE) by prostate tumors and cell lines
45. Effects of mutant p53 expression on human 15-lipoxygenase-promoter activity and murine 12/15-lipoxygenase gene expression: Evidence that 15-lipoxygenase is a mutator gene
46. Concordant induction of 15-lipoxygenase-1 and mutant p53 expression in human prostate adenocarcinoma: Correlation with Gleason staging
47. Reduced 15-lipoxygenase-2 immunostaining in prostate adenocarcinoma: Correlation with grade and expression in high-grade prostatic intraepithelial neoplasia
48. Overexpression of 15-lipoxygenase-1 in PC-3 human prostate cancer cells increases tumorigenesis
49. Oxidized LDL reduces monocyte CCR2 expression through pathways involving peroxisome proliferator-activated receptor gamma
50. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta
51. 15-Deoxy-delta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats
52. Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo
53. 15S-Hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells